Krystal Biotech, Inc. Common Stock

€261
EUR
Last updated on --.
24h volume264.46K
24h highest271.74 EUR
24h lowest260.63 EUR
24h Price movement-0.18%

KRYS recent prices

24 Hours
-0.18%-€0.4691
30 days
-1.72%-€4.561
60 days
+13.72%+€31.48
90 days
+16.16%+€36.32

Key data

Previous close261.48 EUR
Market cap7.71B EUR
Volume264.46K
P/E ratio39.430000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)6.6282 EUR
Net income (FY)195.48M EUR
Revenue (FY)362.51M EUR
Last report dateMay 4, 2026

About Krystal Biotech, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersPITTSBURGH
Employees (FY)295.00
Revenue per employee (FY)1.23M EUR
Net income per employee (FY)662.66K EUR
Listed onNasdaq
Official website

KRYS conversion tables

KRYSKRYS
EUREUR
0.5 KRYS130.5 EUR
1 KRYS261 EUR
5 KRYS1,305.04 EUR
10 KRYS2,610.09 EUR
EUREUR
KRYSKRYS
0.5 EUR0.0019156 KRYS
1 EUR0.0038313 KRYS
5 EUR0.019156 KRYS
10 EUR0.038313 KRYS

FAQ

KRYS is trading at €261.00, -0.18% over the last 24 hours. Track live moves on the price chart at the top of this page.
The KRYS stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. KRYS is currently trading at €261.00, -0.18% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on KRYS price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. KRYS's P/E ratio is currently 39.430000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from KRYS; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against KRYS's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Krystal Biotech, Inc. Common Stock's market cap is currently 7.71B EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume264.46K
24h highest271.74 EUR
24h lowest260.63 EUR
24h Price movement-0.18%
KRYSKRYS
EUREUR
Start trade with KRYS Perpetual